A new study finds that an AI-supported screen reading procedure can contribute to the early detection of breast cancer.

For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 ...

Marla Anderson, MD, a board-certified surgeon, shares practical advice for living with metastatic breast cancer and tips for ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

Paolo Tarantino, MD, PhD, discusses elacestrant as a treatment option for patients with ESR1-mutated metastatic breast cancer in the second line.